Anti-cancer drugs such as the pan-Bcl-2 inhibitor obatoclax (OBX) have been shown to strongly stimulate BiP translocation to the cell membrane in multiple myeloma (MM) cells [52]. This evidence concerns the gene BCL2 and cancer.